BSEBoard Meeting2 Nov 2026 · 2 Nov 2026, 06:35 pm

Shanmuga Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Unaudited Financial Results for the quarter and half year ended 30th September 2026 and Declaration of 1st interim dividend, if any, for the Financial Year 2026-27

Shanmuga Hospital Ltd · 544365

✦ AI SummaryResults

Shanmuga Hospital Ltd has scheduled a board meeting on 12/11/2026 to consider unaudited financial results for Q2 FY2026-27 and declare 1st interim dividend, if any.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Shanmuga Hospital Ltd - 544365 - Board Meeting Intimation for Consideration Of Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2026 And Declaration Of 1St Interim Dividend, If Any, For The Financial Year 2026-27

Attachments (1)

📄

90d1bfca-a03a-40dc-a263-d5811099c1cd.pdf

pdf

Download →
View document text
SHANMUGA HOSPITAL LIMITED Formerly known as Shanmuga Hospital Private Limited Reg. Off: 51/24, Saradha College Road, Salem—636 007. CIN: L85110TZ2020PLC033974 | GSTIN: 33ABDCS8326A 1ZP Tele: 0427-2706674 |E-mail: secretarial@shanmugahospital.com Website: www.shanmugahospital.com ISIN: INE0TD301017 | Symbol: SHANMUGA |Script Code: 544 365 SHL/SE/2026-27/39 02/11/2026 The Listing Department BSE Limited P. J. Towers, Dalal Street, Mumbai-40000, Maharashtra Scrip Code: 544365 | ISIN: INE0TD301017 SUB: Intimation of Board Meeting under Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/ Madam, Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, notice is hereby given that the meeting of the Board of Directors of Shanmuga Hospital Limited (“The Company”) will be held on Thursday, November 12, 2026 to consider the following inter alia; a. To Declare the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026 b. Declaration of 1st Interim dividend, if any, on the equity share capital of the Company for the Financial Year 2026-27. c. Any other business with the permission of the Chair. Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and in accordance with the Company’s Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company is already closed with effect from October 01, 2026 and shall continue to remain closed till 48 (forty-eight) hours after the declaration of the unaudited financial results of the Company for the quarter and half year ended September 30, 2026. This is for your information and records. Thanking you For Shanmuga Hospital Limited Kannan Anjana Maragatham Company Secretary & Compliance Officer M. No. A70080 SECRE TARIAL DEPARTMENT Comp liance Officer: CS Anjana Maragatham E-Mail : cs@smrft.org